Avisa Diagnostics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FOGCF research report →
About the company
Avisa Diagnostics Inc. is a medical device company currently in its clinical development phase. The company is advancing the Avisa BreathTest, an innovative drug-device biomarker platform.
- CEO
- David S. Joseph
- IPO
- 2021
- Employees
- 3
- HQ
- Santa Fe, NM, US
Price Chart
- Market Cap
- $97.18K
- P/E
- -0.23
- P/S
- 0.31
- P/B
- -0.31
- EV/EBITDA
- -0.19
- Div Yield
- 0.00%
- Gross Margin
- 46.53%
- Op Margin
- -251.59%
- Net Margin
- -263.83%
- ROE
- 408.59%
- ROIC
- 187.73%
- Revenue
- $277.83K · -67.63%
- Net Income
- $-715,762 · 82.69%
- EPS
- $-0.14 · 83.72%
- Op Income
- $-900,655
- FCF YoY
- 67.09%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.28
- Avg Volume
- 111.41K
Get TickerSpark's AI analysis on FOGCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FOGCF coverage
Recent articles, reports, and earnings notes.
No research on FOGCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FOGCF report →Similar companies
Peers in the same neighborhood.